Home
Categories
Ingredients
Packaging
Regulatory
Manufacturing
Body Care
Colour Cosmetics
Fragrance
Hair Care
Skin Care
Male Grooming
Digital
Marketing
Retail
Distribution
Pure Beauty
Careers
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company
Evocutis
Evocutis
Activities:
Regulatory
Research & Development
Skin Care
Share
X
LinkedIn
Facebook
Trending Articles
The Body Shop's downfall triggered by failing to secure credit
The beauty company’s owner Aurelius Group failed to secure new funding, according to reports in The Telegraph
You need to be a subscriber to read this article.
Click here
to find out more.
Future beauty forecasting from in-cosmetics Global 2024
Longevity, pre-ageing and AI-empowered ingredients were some standout themes from the Paris ingredients trade show last week
Puig sets IPO target for close to €14 billion
The Spanish beauty giant plans to sell Class B shares at €22 to €24.50 each, which would value the group between €12.7bn and €13.9bn
Exclusive: CeraVe hits the road with ‘myth-busting’ skin care tour
The CeraVe High University Roadshow will visit ten UK universities to debunk the biggest myths surrounding treating acne-prone skin
Paris Hilton launches debut self-tanning line with Tan-Luxe
A viral TikTok video sees Hilton discussing a tagline for her new self-tanning collection with an artificial intelligence (AI) version of herself
Upcoming event
China Beauty Expo
22-24 May | Shanghai, China
See all
Related Content
Skin Care
Venn Life Sciences acquires trading assets of Evocutis
Including intellectual property rights to Labskin and anti-acne compound SYN1113
Finance
Evocutis announces 2013 interim results
Revenue reaches £226,000
Regulatory
Evocutis and Bradford University Collaborate on pigmented LabSkin
Aim to discover improved ways of investigating common pigment-related skin conditions
Regulatory
Evocutis secures first contracts for LabSkin living skin equivalent
Offers an alternative to ethically sensitive and expensive animal and human volunteer testing
Regulatory
Evocutis introduces versatile 3D human skin model
LabSkin launched as a consumable research tool
Regulatory
Evocutis joins IVTIP
LabSkin technology recognised
Ingredients
Evocutis launches testing panel for anti-acne ingredients
Evocutis has launched a panel of 36 strains of <i>Propionibacterium acnes</i>
Subscribe now